Johannes S Kern Selected Research

Johannes S Kern Research Topics

7	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2022 - 10/2005
5	Bullous Pemphigoid (Pemphigoid) 12/2022 - 11/2008
4	Pemphigus (Pemphigus Vulgaris) 12/2021 - 01/2010
3	Blister (Bulla) 12/2022 - 01/2010
3	Skin Diseases (Skin Disease) 12/2022 - 01/2013
3	Cicatrix (Scar) 01/2022 - 12/2016
3	Inflammation (Inflammations) 01/2018 - 09/2009
2	Hidradenitis Suppurativa 01/2023 - 08/2020
2	Congenital Abnormalities (Deformity) 01/2023 - 05/2008
2	Epidermolysis Bullosa 01/2023 - 01/2013
2	Pathologic Constriction (Stenosis) 12/2022 - 12/2016
2	Fibrosis (Cirrhosis) 01/2022 - 09/2015
2	Melanoma (Melanoma, Malignant) 01/2018 - 06/2017
2	Neoplasms (Cancer) 01/2018 - 02/2016
1	Tics (Tic) 01/2023
1	Cutaneous Mastocytosis 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2021
1	Virus Diseases (Viral Diseases) 02/2020
1	Herpesviridae Infections (Herpesvirus Infection) 02/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Disease Susceptibility (Diathesis) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Esophageal Stenosis (Esophageal Stricture) 12/2016
1	Carcinogenesis 02/2016
1	Papilloma (Papillomatosis) 02/2016
1	Linear IgA Bullous Dermatosis 03/2014
1	Ulcerative Colitis 03/2014
1	Wounds and Injuries (Trauma) 11/2011
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2010

7	CollagenIBA 01/2022 - 05/2008
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
5	Collagen Type XVIIIBA 01/2019 - 11/2008
4	AutoantibodiesIBA 08/2021 - 11/2008
3	AntibodiesIBA 01/2018 - 09/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2020 - 01/2010
2	IntegrinsIBA 02/2016 - 11/2011
2	AntigensIBA 12/2014 - 07/2012
1	SolutionsIBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	TriterpenesIBA 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 12/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Rituximab (Mabthera)FDA Link 12/2021
1	Interleukin-23 (Interleukin 23)IBA 08/2021
1	tildrakizumabIBA 08/2021
1	Adalimumab (Humira)FDA Link 08/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	EnzymesIBA 01/2018
1	BiglycanIBA 06/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2016
1	CarcinogensIBA 02/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 02/2016
1	Losartan (Cozaar)FDA LinkGeneric 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Immunoglobulin A (IgA)IBA 03/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2010
1	Desmoglein 3IBA 01/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2010
1	Azathioprine (Imuran)FDA LinkGeneric 01/2010
1	Dapsone FDA Link 01/2010
1	CytokinesIBA 09/2009
1	Collagen Type VIIIBA 10/2005

9	Therapeutics 12/2022 - 05/2008
1	Injections 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2009
1	Intradermal Injections 09/2009